Eisai Satisfies All-Case Surveillance Requirement for Anticancer Agent Remitoro
TOKYO, May 16, 2025 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. announced today that it has received notification from Japan’s Ministry of Health, Labour, and Welfare (MHLW) that...